Lilly says it will raise drug prices in Europe, responding to Trump threats
Written by
BioPharma Dive
Published
0
comments
0
min
As the Trump administration works to implement a “most-favored nation” policy, Lilly said it’s “rebalancing” prices to “align” costs across different countries.